The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer
Open accessAbstract
Background and aims: There is a need for objective easily determined pathological prognostic parameters in Dukes' B colon carcinoma to allow selection of such patients for further treatment as the role of adjuvant chemotherapy for these patients remains unclear. This study was initiated to assess the influence of pathological factors on prognosis in an unselected prospective series of Dukes' B colonic cancer. Methods: The Gloucester Colorectal Cancer study, established in 1988, recruited more than 1000 cases. Meticulous pathological assessment of the 268 Dukes' B colonic cancer resections in this series included evaluation of all pathological factors that could influence staging and prognosis. All patients entered a comprehensive follow up system. Results: Four pathologically determined factors—peritoneal involvement, venous spread (both submucosal and extramural), spread to involve a surgical margin, and perforation through the tumour—were independent prognostic factors in multivariate analysis. Combining these four factors into a simple cumulative scoring system generated clinically useful prognostic groups. Conclusions: The cumulative prognostic index allows apportionment of patients with Dukes' B colon cancer into defined prognostic groups, which in turn could allow more objective selection of patients for adjuvant therapy, especially as part of clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,256
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
Quirke, P., Dixon, M. F., Durdey, P., & Williams, N. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92612-7 · Cited by 1,973
Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
(1995) · The Lancet · doi:10.1016/s0140-6736(95)90696-7 · Cited by 1,066
Role of circumferential margin involvement in the local recurrence of rectal cancer
Adam, I. J., Martin, I. G., Finan, P., Johnston, D., Mohamdee, M. O., Scott, N., Dixon, M. F., & Quirke, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92206-3 · Cited by 1,036
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Tangen, C. M., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00001 · Cited by 925
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 816
The Spread of Rectal Cancer and its Effect on Prognosis
Dukes, C. E., & Bussey, H. J. R. (1958) · British Journal of Cancer · doi:10.1038/bjc.1958.37 · Cited by 802
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
A NEW PROGNOSTIC CLASSIFICATION OF RECTAL CANCER
Jass, J. R., Love, S. B., & Northover, J. M. A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90552-6 · Cited by 701
Self-citationWolmark, N., Rockette, H., Fisher, B., Wickerham, D. L., Redmond, C., Fisher, E. R., Jones, J., Mamounas, E. P., Ore, L., & Petrelli, N. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1879 · Cited by 689
Cited by
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Skrede, O.-J., De Raedt, S., Kleppe, A., Hveem, T. S., Liestøl, K., Maddison, J., Askautrud, H. A., Pradhan, M., Nesheim, J. A., Albregtsen, F., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32998-8 · Cited by 627
Self-citationIncidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
Segelman, J., Granath, F., Holm, T., Machado, M., Mahteme, H., & Martling, A. (2012) · British Journal of Surgery · doi:10.1002/bjs.8679 · Cited by 507
The Staging of Colorectal Cancer: 2004 and Beyond
Compton, C. C., & Greene, F. L. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.6.295 · Cited by 460
Gray, R. G., Quirke, P., Handley, K., Lopatin, M., Magill, L., Baehner, F. L., Beaumont, C., Clark-Langone, K. M., Yoshizawa, C. N., Lee, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.8732 · Cited by 380
Tumor Budding is a Strong and Reproducible Prognostic Marker in T3N0 Colorectal Cancer
Wang, L. M., Kevans, D., Mulcahy, H., O'Sullivan, J., Fennelly, D., Hyland, J., O'Donoghue, D., & Sheahan, K. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318184cd55 · Cited by 280
S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008
Schmiegel, W., Reinacher-Schick, A., Arnold, D., Graeven, U., Heinemann, V, Porschen, R., Riemann, J., Rödel, C., Sauer, R., Wieser, M., et al. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027726 · Cited by 274
Hari, D. M., Leung, A. M., Lee, J.-H., Sim, M.-S., Vuong, B., Chiu, C. G., & Bilchik, A. J. (2013) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2013.04.018 · Cited by 263
Betge, J., Pollheimer, M. J., Lindtner, R. A., Kornprat, P., Schlemmer, A., Rehak, P., Vieth, M., Hoefler, G., & Langner, C. (2012) · Cancer · doi:10.1002/cncr.26310 · Cited by 260
Metadata
- Authors
- Petersen, V. C., Baxter, K. J., Love, S. B., & Shepherd, N. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2002-07
- Volume
- 51
- Issue
- 1
- Pages
- 65-69
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2096571184
- Cited by
- 273
- References
- 23
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.